LYNK Pharmaceuticals

China
Hengyang, Hunan, China, 310018

Company profile

LYNK Pharmaceuticals company profile

LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.

Business identity

Contact email
[email protected]
Phone number
+86 0571-8771117
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2018-01-01, Year

Headquarters

Postal code
310018
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
7
Total equity funding
$124.8M
Last funding
Series C / $16.7M / 2023-09-21
Last equity funding
Series C / $16.7M
Investors
17
Lead investors
4
Founders
4
Articles
38

Founders and investors

Founders

Jardo CheinJun WangMichael VazquezZhao-Kui Wan

Lead investors

Decheng CapitalKaitai CapitalLegend CapitalLilly Asia Ventures

Investors

Decheng CapitalLegend CapitalLilly Asia VenturesMed-Fine CapitalSinopharm Capital